Envoke raises £1.6m seed to cut lab downtime with virtual simulations
This article covers Envoke, a SaaS startup, which has closed a seed funding round of £1.6m from NPIF (Mercia Equity Finance), Finance Yorkshire’s Seedcorn Fund and Foresight Group to accelerate international expansion for its virtual training and maintenance software for laboratory equipment. The funding aims to support Envoke’s Asia-Pacific expansion, product development and scaling of recurring revenue, supporting laboratory equipment manufacturers and healthcare providers.
Envoke, a SaaS startup, has closed a seed funding round of £1.6 million from NPIF – Mercia Equity Finance, Finance Yorkshire’s Seedcorn Fund and Foresight Group to accelerate international expansion for its virtual training and maintenance software for laboratory equipment. The Leeds-based company says the money will fund growth into Asia-Pacific and product development as it seeks to scale recurring revenue.
Why it matters
Envoke’s software addresses an operational pinch point for both laboratory equipment manufacturers and healthcare providers: costly engineer call-outs and equipment downtime. The company reports its platform can cut service visits by 15 to 20 per cent and notes a typical on-site service call costs manufacturers around $2,500. For clinical labs, fewer breakdowns translate into more consistent testing and fewer delayed results.
The deal also underlines continued public and regional backing for tech businesses in the north of England, with NPIF involvement signalling the role of funds that aim to boost local commercialisation and international growth.
Inside the product
Envoke builds virtual replicas of laboratory machines and packages them into interactive simulations. The platform is used for remote training, troubleshooting and maintenance so that staff can learn operation workflows and technicians can diagnose issues without requiring an on-site visit. The system also provides analytics to monitor user competence and identify training gaps.
Major customers named include Bio-Rad and ThermoFisher Scientific, both global laboratory equipment manufacturers; PacBio, a DNA sequencing firm; Haemonetics, a blood-management company; the NHS, representing UK health services; Hawai’i’s national blood laboratories; and the Mayo Clinic, a leading US medical centre. These customers demonstrate both manufacturer and clinical adoption, which helps validate use cases across product support and operator training.
Envoke currently employs 16 people, including two in the US, expects to add three to five UK roles over the next year, and says total funding to date now exceeds £4 million. The company expects to surpass £1 million in annual recurring revenue within 12 months.
Who are the investors?
The round was financed by NPIF – Mercia Equity Finance, Finance Yorkshire’s Seedcorn Fund and Foresight Group. NPIF refers to the Northern Powerhouse Investment Fund, which is backed by the British Business Bank and delivered through regional managers in England. Finance Yorkshire runs regional investment programmes aimed at early-stage businesses, while Foresight Group is a growth investor with an international portfolio.
Investors cite Envoke’s traction with US multinationals, customer feedback on reduced service costs and the release of a new platform version as reasons to back the business. The funding is positioned to help accelerate international expansion, with Asia-Pacific highlighted as a priority.
In the announcement, Dawn Tyler, Investor at Mercia Ventures, said:
Envoke has come a long way since our original investment three years ago. The business has built an impressive client base among US multinationals, achieved very positive customer feedback and launched a new platform that is the most powerful to date. With growing global demand for virtual training and maintenance systems, Envoke is now well positioned to reach out to an even wider international audience.
In the announcement, Line Gauteplass, Investor at Foresight Group, said:
Envoke has developed a highly compelling platform that addresses real operational challenges for both laboratory equipment manufacturers and healthcare providers. The business has already demonstrated strong traction with leading global customers, and we see significant potential as it expands internationally, particularly across Asia-Pacific. We are pleased to support Stuart and the team as they scale the business and build on this next phase of growth.
In the announcement, Debbie Sorby, Investor at British Business Bank, said:
It is encouraging to see the Northern Powerhouse Investment Fund continuing to support Envoke as it advances through its growth journey, illustrating how the fund enables businesses to scale over time. The business has made strong progress to date, establishing a robust customer base and delivering technology that addresses well-defined challenges in laboratory training and maintenance.
If you're researching potential backers in this space:
- Explore our list of saas venture capital firms in the UK
- Browse our directory of saas angel investors in the UK
Founder perspective
In the announcement, Stuart Warrington, Founder & CEO at Envoke, said:
Laboratory equipment is challenging to operate and technical problems are commonplace. Each service call-out typically costs manufacturers $2,500 and a breakdown can seriously disrupt health services by delaying critical test results. Envoke is tackling these problems. Customer feedback shows our system helps laboratories to reduce downtime and provide more consistent operator training, while enabling manufacturers to cut service costs and boost revenue.
The bigger picture
The funding highlights interest in tools that reduce operational friction in healthcare and laboratory settings, and it is a reminder that software-first approaches to training and remote maintenance can unlock cost savings across equipment lifecycles. For the UK ecosystem, the round is an example of regional funds and growth investors collaborating to push a northern tech business into international markets.
As Envoke pursues Asia-Pacific expansion, the outcome will be a useful case study for other UK startups building specialised enterprise SaaS for regulated sectors such as healthcare and diagnostics.
Click here for a full list of 7,589+ startup investors in the UK